Skip page header and navigation

Hill Dickinson advises Helios Global Group on Cogentia acquisition

Hill Dickinson advises Helios Global Group on Cogentia acquisition

Commercial law firm Hill Dickinson’s private equity team has advised Helios Global Group on its acquisition of Cambridge-based Cogentia, a health economics and outcomes research (HEOR) and market access consultancy. 

Helios, a full-service healthcare communications group working with some of the world’s leading pharmaceutical and biotech clients, is backed by the Manchester-based private equity firm, NorthEdge. 

The acquisition will strengthen the group’s service offering to the life sciences sector and will enable Helios to further expand its specialist services for clients and increase its global talent base.

Hill Dickinson’s head of private equity, David Mkhitarian, and senior associate Katy Oakes advised Helios on the transaction, with support from Tasha Millar and Nazmin Choudhury and Paula Mas Alvarez.

Commenting on the deal, David Mkhitarian said: “The opportunity for Helios to acquire a UK business whose specialism in HEOR and market access complements its own ambitions and extends its global capabilities made sound commercial sense. Ongoing financial backing from NorthEdge has enabled this to happen and we are pleased to have provided legal advice to the team at Helios throughout the process.” 

Since NorthEdge first invested in Helios in 2021, the company has more than doubled its revenues, grown its headcount from 100 to 250 and expanded its global operations across Manchester, Oxford, and Connecticut in the USA.

Cogentia is recognised as one of the UK’s leading market access consultancies, handling projects across numerous therapeutic areas in markets throughout the world. It undertakes research and data-led health analysis for a range of global pharmaceutical and healthcare companies, supporting them in getting their products to market and ensuring patient uptake.
 

If you are exploring any elements of a private equity transaction, whether it is MBOs, MBIs, secondary buyouts or exits, we are here to help.

How we can advise you

You can draw on the experience of a team that has advised clients on MBOs, MBIs, institutional purchases and public to private transactions. We are also experienced in early stage seed or venture capital investment and further funding rounds through to secondary buy-outs and bolt-on acquisitions and exits across all sectors.

Our specialist team has strong links with investors and equity houses in the local North West region and national private equity markets, which can help furnish opportunities and introductions for your business seeking investment for growth.

Our team is also a respected leading advisor to management teams, knowledgeable in market price and the points that matter to help protect your value to exit, providing, clear commercial advice to help secure the investment you are seeking.

You can have confidence that the way in which we manage risk for our clients protects their investments and delivers deals on time and on budget.